loadpatents
name:-0.031929016113281
name:-0.025089979171753
name:-0.00064897537231445
Reger; Thomas S. Patent Filings

Reger; Thomas S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Reger; Thomas S..The latest application filed is for "5,5-bicyclic oxazole orexin receptor antagonists".

Company Profile
0.23.30
  • Reger; Thomas S. - Lansdale PA
  • REGER; Thomas S. - US
  • REGER; Thomas S. - West Point PA US
  • Reger; Thomas S. - San Diego CA
  • Reger, Thomas S - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methyl diazepane orexin receptor antagonists
Grant 10,000,499 - Kuduk , et al. June 19, 2
2018-06-19
Bridged diazepane orexin receptor antagonists
Grant 9,994,570 - Kuduk , et al. June 12, 2
2018-06-12
5,5-bicyclic oxazole orexin receptor antagonists
Grant 9,987,255 - Kuduk , et al. June 5, 2
2018-06-05
5,5-Bicyclic Oxazole Orexin Receptor Antagonists
App 20170368035 - Kuduk; Scott D. ;   et al.
2017-12-28
Bridged Diazepane Orexin Receptor Antagonists
App 20170320876 - KUDUK; SCOTT D. ;   et al.
2017-11-09
Methyl Diazepane Orexin Receptor Antagonists
App 20170305916 - KUDUK; SCOTT D. ;   et al.
2017-10-26
Diazepane orexin receptor antagonists
Grant 9,732,077 - Kuduk , et al. August 15, 2
2017-08-15
Pyrimidine PDE10 inhibitors
Grant 9,663,513 - Kuduk , et al. May 30, 2
2017-05-30
Diazepane Orexin Receptor Antagonists
App 20160318923 - KUDUK; SCOTT D. ;   et al.
2016-11-03
Secondary alcohol substituted triazoles as PDE10 inhibitors
Grant 9,428,492 - Kuduk , et al. August 30, 2
2016-08-30
Cyclopropyl imidazopyridine PDE10 inhibitors
Grant 9,359,348 - Kuduk , et al. June 7, 2
2016-06-07
Substituted pyridizinone derivatives as PDE10 inhibitors
Grant 9,353,104 - Kuduk , et al. May 31, 2
2016-05-31
Cyclobutyl benzimidazoles as PDE 10 inhibitors
Grant 9,284,302 - Kuduk , et al. March 15, 2
2016-03-15
Substituted pyridone derivatives as PDE10 inhibitors
Grant 9,273,033 - Kuduk , et al. March 1, 2
2016-03-01
Substituted Pyridizinone Derivatives As Pde10 Inhibitors
App 20160016947 - Kuduk; Scott D. ;   et al.
2016-01-21
Cyclopropyl Imidazopyridine Pde10 Inhibitors
App 20150307488 - Kuduk; Scott D. ;   et al.
2015-10-29
Pyrimidine Pde10 Inhibitors
App 20150307489 - Kuduk; Scott D. ;   et al.
2015-10-29
Cyclobutyl Benzimidazoles As Pde 10 Inhibitors
App 20150307479 - Kuduk; Scott D. ;   et al.
2015-10-29
Substituted Pyridone Derivatives As Pde10 Inhibitors
App 20150291561 - Kuduk; Scott D. ;   et al.
2015-10-15
Secondary Alcohol Substituted Triazoles As Pde10 Inhibitors
App 20150284368 - Kuduk; Scott D. ;   et al.
2015-10-08
Macrocyclic Compounds As Hiv Integrase Inhibitors
App 20150203512 - Reger; Thomas S. ;   et al.
2015-07-23
Heterocycle phenyl amide T-type calcium channel antagonists
Grant 8,637,513 - Barrow , et al. January 28, 2
2014-01-28
Isonicotinamide orexin receptor antagonists
Grant 8,592,457 - Bergman , et al. November 26, 2
2013-11-26
Tripyridyl carboxamide orexin receptor antagonists
Grant 8,349,872 - Coleman , et al. January 8, 2
2013-01-08
Pyridyl amide T-type calcium channel antagonists
Grant 8,263,627 - Barrow , et al. September 11, 2
2012-09-11
Pyridine Carboxamide orexin Receptor Antagonists
App 20110301140 - Bergman; Jeffrey M. ;   et al.
2011-12-08
Pyridine carboxamide orexin receptor antagonists
Grant 8,003,797 - Bergman , et al. August 23, 2
2011-08-23
Isonicotinamide Orexin Receptor Antagonists
App 20110201591 - Bergman; Jeffrey M. ;   et al.
2011-08-18
Pyridyl Amide T-Type Calcium Channel Antagonists
App 20110112064 - Barrow; James C. ;   et al.
2011-05-12
Pyridyl amide T-type calcium channel antagonists
Grant 7,875,636 - Barrow , et al. January 25, 2
2011-01-25
Heterocycle Phenyl Amide T-type Calcium Channel Antagonists
App 20100261724 - Barrow; James C. ;   et al.
2010-10-14
Heterocycle Amide T-type Calcium Channel Antagonists
App 20100249176 - Barrow; James C. ;   et al.
2010-09-30
Pyridine Carboxamide Orexin Receptor Antagonists
App 20100197652 - Bergman; Jeffrey M. ;   et al.
2010-08-05
Tripyridyl Carboxamide Orexin Receptor Antagonists
App 20100035931 - Coleman; Paul J. ;   et al.
2010-02-11
Pyridyl Amide T-Type Calcium Channel Antagonists
App 20090275550 - Barrow; James C. ;   et al.
2009-11-05
Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
Grant 7,592,337 - Chen , et al. September 22, 2
2009-09-22
VLA-4 antagonists
Grant 7,514,409 - Hagmann , et al. April 7, 2
2009-04-07
VLA-4 Antagonists
App 20090069376 - Liu; Ping ;   et al.
2009-03-12
Prodrugs of (2R)-2-propyloctanoic acid for the treatment of stroke
Grant 7,495,029 - Munoz , et al. February 24, 2
2009-02-24
Prodrugs of (2R)-2-Propyloctanoic Acid For the Treatment of Stroke
App 20080132488 - Munoz; Benito ;   et al.
2008-06-05
Heteroaryl substituted tetrazole modulators of metabotrophic glutamate receptor-5
Grant 7,253,190 - Cosford , et al. August 7, 2
2007-08-07
Vla-4 antagonists
App 20070179190 - Hagmann; William K. ;   et al.
2007-08-02
Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
App 20050153986 - Chen, Chixu ;   et al.
2005-07-14
Nitric oxide releasing drugs for Alzheimer's disease
App 20050054714 - Munoz, Benito ;   et al.
2005-03-10
Heteroaryl substituted tetrazole modulators of metabotrophic glutamate receptor-5
App 20040186295 - Cosford, Nicholas D P ;   et al.
2004-09-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed